ZBH - CIK 0001136869
ZIMMER BIOMET HOLDINGS, INC. trades as ZBH and has a market capitalization of $17.06 B, making it the #677 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $8.23B, up 7.2% from the prior year and net income of $705.10M. This page tracks ZIMMER BIOMET HOLDINGS, INC. through 1,000 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years ZIMMER BIOMET HOLDINGS, INC.'s revenue grew from $7.67B to $8.23B, a compound annual growth rate of 0.8%. Net profit margin expanded from 4.0% to 8.6% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-19 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Insider sale notice | 144 | 2026-05-12 |
| Major company event | 8-K | 2026-05-12 |
| Insider trade | 4 | 2026-05-05 |
| Quarterly report | 10-Q | 2026-05-01 |
| SCHEDULE 13G | - | 2026-04-30 |
| Major company event | 8-K | 2026-04-28 |
WARSAW, Ind. , May 22, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2026. The cash dividend of $0.24 per share is payable on or about July 31, 2026 to stockholders of record as of the close of business on June 25, 2026.
WARSAW, Ind. , May 12, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.
WARSAW, Ind. , May 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Bank of America Securities Health Care Conference on Wednesday, May 13, 2026, with a fireside chat at 8:40 a.m. PT (11:40 a.m. ET).
WARSAW, Ind. , April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance, Operations and Supply Chain, will depart the company effective April 28 for a new professional opportunity.
The largest companies sharing ZIMMER BIOMET HOLDINGS, INC.'s SEC industry classification (orthopedic, prosthetic & surgical appliances & supplies).
ZIMMER BIOMET HOLDINGS, INC. (ZBH) has a market capitalization of $17.06 B as of 2026-06-10, ranking #677 among US-listed companies.
ZIMMER BIOMET HOLDINGS, INC. reported revenue of $8.23B for fiscal year 2025, an increase of 7.2% year over year.
Yes. ZIMMER BIOMET HOLDINGS, INC. reported net income of $705.10M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
WARSAW, Ind. , April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2026. The Company reported first quarter net sales of $2.087 billion, an increase of 9.3% over the prior year period, an increase of 6.8% on a constant currency 1 basis and an increase of 2.9% on an organic constant currency 1 basis. Net earnings for the first quarter were $238.1 million, or $409.4 million on an adjusted 1 basis.